The Health Insurance Review Assessment and Service announced on September 13 that health insurance will no longer cover a total of 285 antihypertensive agents which have been on market since 2006.
The agency said these drugs are judged to be less cost-effective items.
However, pharmaceutical firms are less nervous about the HIRA’s assessment.
“We’ve already known the results of HIRA’s ...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.